lorcaserin(856681-05-5)is an orally administered agent and a selective 5-ht2c receptor agonist for the treatment of obesity. it had been approved for marketing in us by fda on 27 june in 2012. in clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
product name: m-toluic acid
structural formula:
cas: 99-04-7
einecs: 202-723-9
molecular formula: c8h8o2
molecular weight: 136.132
melting point:108-110℃
boiling point:263℃
purum: ≥ 99%
appearance:white laminated shape crystallization.
applications:medicine, agricultural chemicals intermediate. mainly uses in producing drives the insect medicinal preparation.
package:according to user request packing.